Abstract
Clinical and histological data of children presenting with steroid-resistant nephrotic syndrome and renal biopsy showing focal and segmental glomerulosclerosis from 1980 with a follow-up of over 10 years were reviewed. There were 66 patients; 38 male and 28 female. Age at onset ranged from 0.4–14.1 years (mean 6.4). Tubular atrophy was present at first biopsy in 50/66, capsular adhesions in 35/66, glomerular tip lesions in 8/66 and mesangial expansion in 31/66 patients. In 51 children, cyclophosphamide was prescribed as the first cytotoxic agent, while 15 received cyclosporine A and complete remission was induced in 43 and 40% of the children, respectively. Complete and stable remission was maintained in 35 children, while 22 had reduction of proteinuria with symptomatic relief. Nine were refractory to cytotoxic therapy. Of the 35 patients who entered complete and stable remission, the renal survival was over 90%, while in the 31 non-responders it was 48% in 10 years. The multivariate analysis using unconditional logistic regression method identified the presence of mesangial expansion (p=0.011) and tip lesions (p=0.005) as the independent predictors of favourable response to cytotoxic therapy and the presence of renal impairment (p=0.008) and extensive focal segmental sclerosis (p=0.025) as independent predictors of unfavourable response.
Similar content being viewed by others
References
White RHR, Glasgow EF, Mills RJ (1970) Clinicopathological study of nephrotic syndrome in childhood. Lancet 1:1353–1359
Beaufils H, Alphonse JC, Guedon J, Legrain M (1978) Focal glomerulosclerosis: natural history and treatment. Nephron 21:75–85
Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213–218
Trompeter RS (1989) Immunosuppressive therapy in nephrotic syndrome in children. Pediatr Nephrol 3:218–220
Burgess E (1999) Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int Suppl 55(S70):S26–S32
Habashy D, Hodson EM, Craig JC (2003) Interventions for steroid-resistant nephrotic syndrome: a systematic review. Pediatr Nephrol 18:906–912
Abeyagunawardena A, Brogan PA, Trompeter RS, Dillon MJ (2002) Immunosuppressive therapy of childhood idiopathic nephrotic syndrome. Expert Opin Pharmacother 3:513–519
Bazzi C, Petrini C, Rizza V, Arrigo G, D’Amico G (2000) A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int 58:1732–1741
Detwiler RK, Falk RJ, Hogan SL, Jennette JC (1994) Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416–1426
Southwest Pediatric Nephrology Study Group (1985) Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 27:442–449
Consensus statement on management and audit potential for steroid responsive nephrotic syndrome (1994) Report of a workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians. Arch Dis Child 70:151–157
Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P (1987) Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 82:938–944
Tarshish P, Tobin JN, Bernstein J, Edelmann CM (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10:590–593
Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy of prednisolone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43:84–88
Martinelli R, Okumura AS, Pereira LJ, Rocha H (2001) Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr Nephrol 16:658–661
Singh A, Tejani C, Tejani A (1999) One-center experience with cyclosporine in refractory nephrotic syndrome in children. Pediatr Nephrol 13:26–32
Niaudet P (1994) Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisolone. J Pediatr 125:981–986
Goonasekera CDA, Koziell AB, Hulton SA, Dillon MJ (1998) Vincristine and focal segmental sclerosis: do we need a multicentre trial? Pediatr Nephrol 12:284–289
Abeyagunawardena AS, Abeysekera CK, Thalgahagoda RS, Dillon MJ (2004) Pulsed vincristine therapy in steroid-resistant nephrotic syndrome (abstract). Pediatr Nephrol 6:C119
Ingulli E, Tejani A (1991) Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393–397
Kestila M, Lenkkeri U, Lamerdin J (1998) Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582
Niaudet P (2004) Genetic forms of nephrotic syndrome. Pediatr Nephrol 19:1313–1318
Yu Z, Ding J, Huang J, Yao Y, Xiao H, Zhang J, Liu J, Yang J (2005) Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children. Nephrol Dial Transplant 20:902–908
Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard treatment of nephrotic syndrome. J Am Soc Nephrol 15:722–732
Antignac C (2005) Molecular basis of steroid-resistant nephrotic syndrome. Nefrologia 25:25–28
Schoeneman MJ, Bennett B, Greifer I (1978) The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children. Clin Nephrol 9:45–54
Stokes MB, Markowitz GS, Lin J, Valeri AM, D’Agati VD (2004) Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 65:1690–1702
Ponticelli C (1995) Focal segmental glomerulosclerosis. To treat or not to treat. Nephrol Dial Transplant 10:2351–2354
Shiiki H, Dohi K (2000) Primary focal segmental glomerulosclerosis: clinical course, predictors of renal outcome and treatment. Intern Med 39:606–611
Abrantes MM, Cardoso LS, Lima EM, Penido Silva JM, Diniz JS, Bambirra EA, Oliveira EA (2006) Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis. Pediatr Nephrol 21:1003–1012
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abeyagunawardena, A.S., Sebire, N.J., Risdon, R.A. et al. Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol 22, 215–221 (2007). https://doi.org/10.1007/s00467-006-0264-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0264-6